Vitrafy Life Sciences Ltd. Stock Analysis VFY.AX

Vitrafy Life Sciences Ltd. is a technology company that engages in the research and development of cryopreservation technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2024-11-26. The firm is engaged in the research, development and commercialization of its vertically integrated cryopreservation solution that includes cryopreservation medical devices (freezer, thawer and packaging solutions), LifeChain integrated software system, and application services for identified application areas in human health and animal health services. The firm has developed a proprietary range of smart cryopreservation hardware and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution. Its Lifechain software platform combines the advanced software functions, such as artificial intelligence (AI), machine learning and IoMT integration, to ensure supply chain processes are controlled, traced, tracked and monitored to the standards, and retain the quality of precious biomaterials.